Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Daniel Kim BS

Daniel Y. Kim BS

MD-PhD Student, Harvard Medical School, Harvard-MIT Health Sciences and Technology MD Program, Boston, Massachusetts

Daniel Kim is a medical student enrolled in the Health Sciences and Technology program at Harvard Medical School and the Massachusetts Institute of Technology. After graduating summa cum laude from Cornell University, Daniel pursued research at Massachusetts General Hospital, focusing on the development of new CRISPR-Cas9 gene-editing technologies. His work has been published in top academic journals and has been licensed by several biotechnology companies, where he serves as a scientific consultant.

Over the past few years, Daniel has engaged in melanoma epidemiology research, aiming to better understand the risk factors associated with disease prognosis and survival. He has also conducted studies examining melanoma treatment outcomes within the Veterans Affairs population. Daniel aspires to be an academic dermatologist in the future, merging his passion for medicine and science to help patients with debilitating and challenging dermatologic conditions.


Daniel Kim has no relevant disclosures.